Close

References

  1. Sabatine MS, et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16;372(16):1500-9.
  2. Koren MJ, et al. Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. Circulation. 2014 Jan 14;129(2):234-43.
  3. Keveyis (dichlorphenamide) prescribing information. Taro Pharmaceuticals; Hathorne, NY. August 2015. http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011366s030lbl.pdf
  4. BEGONIA trial investigators. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med. 2013;10:1807-15.
  5. Synjardy (empagliflozin/metformin) prescribing information. Boehringer Ingelheim, Inc. Ridgefield, CT. August 2015. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Synjardy/Synjardy.pdf
  6. Moskowitz CH, et al. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015 May 9;385(9980):1853-62.
  7. OxyContin (oxycodone) prescribing information. Purdue Pharma L.P. Stamford, CT. August 2015. http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022272s027lbl.pdf
  8. Zubsolv (buprenorphine/naloxone) prescribing information. Orexo Pharmaceuticals, Inc. Morristown, NJ. August 2015. http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204242s004lbl.pdf
  9. Procysbi (cysteamine bitartrate) prescribing information. Raptor Pharmaceuticals, Inc. Novato, California. August 2015. http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203389s010lbl.pdf
  10. Grainger JD, et al. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet. 2015 Jul 28. pii: S0140-6736(15)61107-2.
  11. Behrens G, et al. Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis. AIDS Patient Care STDS. 2014 Apr;28(4):168-75. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985528/
  12. Aptiom (eslicarbazepine acetate) prescribing information. Sunovion Pharmaceuticals, Inc. Marlborough, MA. August 2015. http://www.aptiom.com/Aptiom-Prescribing-Information.pdf
Close

Contributor Information

Author

Mary L Windle, PharmD
Editor-in-Chief, Medscape Drug Reference

Loading...

  • Google+
  • LinkedIn
EXIT FULLSCREEN

.